Experts will come together to discuss emerging approaches to important challenges and opportunities in the field
The Emirates Pediatric Bone Marrow Transplant & Gene Therapy Congress 2026 will bring leading specialists together to explore the evolving world of pediatric BMT and cellular therapy.
The two-day programme will cover both malignant and non-malignant conditions, from hemoglobinopathies and immune deficiencies to inherited bone marrow and metabolic disorders.
Sessions will also examine pre-transplant assessment, infection management, supportive care and complications during transplantation.
A key focus will be the long-term health of children who have undergone hematopoietic cell transplantation, including the monitoring of late effects.
Experts will share the latest research and clinical updates across bone marrow transplantation, hematologic malignancies and immune effector cell therapy.
Interactive sessions and expert-led presentations will give healthcare professionals practical insights they can take back to clinical practice.
The congress is designed for pediatric oncologists, hematologists, BMT physicians, infectious disease specialists, nurses, laboratory professionals and trainees.
It will also create opportunities to exchange best practices, connect with international peers and explore new approaches to pediatric transplantation.
For anyone working in pediatric BMT, the programme offers a concentrated look at where transplantation and cellular therapy are heading next.
For more information, visit epbmtc.ae
